iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Aug 20, 2026, 4:00 PM EDT
1.452
-0.018 (-1.21%)
After-hours: Aug 20, 2026, 5:33 PM EDT
iBio, Inc. Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 0.3 | 0.4 | 0.23 | - | 1.88 | 2.37 | |
Revenue Growth | -20.00% | 77.78% | - | - | -20.54% | 44.75% |
Cost of Revenue | - | - | - | - | - | 1.46 |
Gross Profit | 0.3 | 0.4 | 0.23 | - | 1.88 | 0.91 |
Selling, General & Admin | 14.95 | 10.69 | 11.67 | 18.45 | 21.75 | 21.89 |
Research & Development | 14.31 | 8.31 | 5.19 | 10.33 | 9.83 | 9.99 |
Operating Expenses | 29.26 | 19 | 16.86 | 28.78 | 31.58 | 31.88 |
Operating Income | -28.96 | -18.6 | -16.63 | -28.78 | -29.7 | -30.97 |
Interest Expense | -0.14 | -0.21 | -0.17 | -0.08 | - | -2.45 |
Interest & Investment Income | 1.5 | 0.44 | 0.36 | 0.21 | 0.18 | 0.14 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.01 | 0.01 |
EBT Excluding Unusual Items | -27.61 | -18.38 | -16.44 | -28.65 | -29.51 | -33.27 |
Gain (Loss) on Sale of Investments | - | - | - | -0.1 | - | - |
Gain (Loss) on Sale of Assets | - | - | 1 | - | - | - |
Asset Writedown | - | - | - | -0.57 | - | -0.14 |
Legal Settlements | - | - | - | - | - | 10.2 |
Pretax Income | -27.61 | -18.38 | -15.44 | -29.31 | -29.51 | -23.21 |
Earnings From Continuing Operations | -27.61 | -18.38 | -15.44 | -29.31 | -29.51 | -23.21 |
Earnings From Discontinued Operations | - | - | -9.46 | -35.7 | -20.79 | - |
Net Income to Company | -27.61 | -18.38 | -24.91 | -65.01 | -50.3 | -23.21 |
Minority Interest in Earnings | - | - | - | - | 0 | 0.01 |
Net Income | -27.61 | -18.38 | -24.91 | -65.01 | -50.3 | -23.21 |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.09 | 0.26 |
Net Income to Common | -27.61 | -18.38 | -24.91 | -65.01 | -50.39 | -23.47 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 71 | 10 | 4 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 71 | 10 | 4 | 1 | 0 | 0 |
Shares Change | 688.29% | 174.05% | 525.98% | 40.35% | 11.45% | 211.53% |
EPS (Basic) | -0.39 | -1.75 | -6.50 | -106.23 | -115.56 | -59.98 |
EPS (Diluted) | -0.39 | -1.75 | -6.50 | -106.23 | -115.56 | -59.98 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -22.17 | -15.32 | -18.76 | -36.87 | -44.81 | -34.98 |
Free Cash Flow Per Share | -0.31 | -1.46 | -4.90 | -60.24 | -102.76 | -89.42 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | 100.00% | 38.34% |
Operating Margin | -9653.00% | -4650.50% | -7392.89% | - | -1576.27% | -1306.12% |
Profit Margin | -9202.00% | -4594.25% | -11069.78% | - | -2674.68% | -989.75% |
Free Cash Flow Margin | -7388.33% | -3830.00% | -8339.56% | - | -2378.45% | -1475.50% |
EBITDA | -28.27 | -17.83 | -15.71 | -28.05 | -29.3 | -28.55 |
D&A For EBITDA | 0.69 | 0.78 | 0.93 | 0.73 | 0.4 | 2.41 |
EBIT | -28.96 | -18.6 | -16.63 | -28.78 | -29.7 | -30.97 |